These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 3549807)

  • 1. Topical minoxidil in early androgenetic alopecia.
    Kreindler TG
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):718-24. PubMed ID: 3549807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of topical minoxidil in the treatment of male pattern baldness.
    Savin RC
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):696-704. PubMed ID: 3549804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgenetic alopecia: treatment results with topical minoxidil.
    Roberts JL
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):705-10. PubMed ID: 3549805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical minoxidil in early male pattern baldness.
    Olsen EA; Weiner MS; Delong ER; Pinnell SR
    J Am Acad Dermatol; 1985 Aug; 13(2 Pt 1):185-92. PubMed ID: 3900155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgenetic alopecia treated with topical minoxidil.
    De Villez RL
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):669-72. PubMed ID: 3549800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response study of topical minoxidil in male pattern alopecia.
    Shupack JL; Kassimir JJ; Thirumoorthy T; Reed ML; Jondreau L
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):673-6. PubMed ID: 3549801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of topical minoxidil therapy for androgenetic alopecia in women.
    Jacobs JP; Szpunar CA; Warner ML
    Int J Dermatol; 1993 Oct; 32(10):758-62. PubMed ID: 8225725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical minoxidil therapy in hereditary androgenetic alopecia.
    De Villez RL
    Arch Dermatol; 1985 Feb; 121(2):197-202. PubMed ID: 3883902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
    Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
    J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of female androgenetic alopecia with minoxidil 2%.
    Whiting DA; Jacobson C
    Int J Dermatol; 1992 Nov; 31(11):800-4. PubMed ID: 1428436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of men with male pattern baldness treated with topical minoxidil.
    Olsen EA; DeLong ER; Weiner MS
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):688-95. PubMed ID: 3549803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.
    DeVillez RL; Jacobs JP; Szpunar CA; Warner ML
    Arch Dermatol; 1994 Mar; 130(3):303-7. PubMed ID: 8129407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical minoxidil therapy for androgenetic alopecia. A 30-month study.
    Koperski JA; Orenberg EK; Wilkinson DI
    Arch Dermatol; 1987 Nov; 123(11):1483-7. PubMed ID: 3314717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy of topical minoxidil in male pattern baldness.
    Katz HI; Hien NT; Prawer SE; Goldman SJ
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):711-8. PubMed ID: 3549806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical minoxidil in male pattern baldness: effects of discontinuation of treatment.
    Olsen EA; Weiner MS
    J Am Acad Dermatol; 1987 Jul; 17(1):97-101. PubMed ID: 3301926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of topical minoxidil in the management of androgenetic alopecia.
    Rietschel RL; Duncan SH
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):677-85. PubMed ID: 3549802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
    Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
    J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
    J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2% topical minoxidil solution in male-pattern baldness: preliminary European results.
    Civatte J; Laux B; Simpson NB; Vickers CF
    Dermatologica; 1987; 175 Suppl 2():42-9. PubMed ID: 3319731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial.
    Penha MA; Miot HA; Kasprzak M; Müller Ramos P
    JAMA Dermatol; 2024 Jun; 160(6):600-605. PubMed ID: 38598226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.